Enjoy it shorts...lol
...GSK receives FDA approval for Arnuity™ Ellipta® (fluticasone furoate) in the US for the treatment of asthma
Some ways its better not to authorize more shares cause the focus is on increasing shareholder value to existing shares.
Buybacks when the stock is deemed bellow norm will only send the stock higher when the market is up
If you're investing for long term income, not a bad choice. But, GSK earnings are forecast to decline or remain flat for several years. And the dividend payout ratio has risen sharply to 86%, which makes it unlikely that there will be any significant increases in the dividend for coming years. There's a chance for a takeover by PFE, so you might have a chance for a premium bonus. I worked at GSK for years, never wanted to own the stock, cashed in options the day they vested. Good luck with your switch, but as a very long term investor, I would much rather hold JNJ than GSK.
and now GSK with NVS OTC will be #1 in OTC with $73B market & #1 in Vaccine with 14% of the market
GSK vat 52 week low!!!
Sentiment: Strong Buy
PLEASE SIGN THIS PETITION
Under the New Jersey Certificate of Incorporate there are 4,322,000,000 common shares authorized. 2,829,099,753 common shares are in shareholder hands. Unless a shareholder vote is taken to increase the authorized shares a one to two split is impossible at this point. Likely the board will hold off such an election for the annual shareholder vote.
And I just realized my math error. That's a 50% increase you're predicting - in a few months. And of course, along with it, a 50% increase in the P/E, from an already borderline high of 20 to a ridiculously high level of 30. Despite the math error, it still took 12 years to get from $50 to $75 after the last split, which is a 4% annual price increase. About what you can expect from a major pharma.
No doubt. It'll be triggered when Republicans take control of the Senate this Fall.
That's just silly wishful thinking. After the 2001 split from $110 to $55, it took 12 YEARS for the stock price to increase by 25%. You're predicting it will do that in a few months? Put me on the side of the doubters.
Europe’s lack of growth could lead to Japanese-style stagnation
The punishing austerity Germany demanded for rescuing the eurozone is creating a vicious cycle in which no one wins
Guess Soros is right about shorting S&P500
Sentiment: Strong Sell
Does George Soros know something we don't about the S&P 500?
Oh, goody. It's 13F time, when mere mortals like us get to see how the big boys rolled the dice in the last quarter.
Among the highlights, Soros Fund Management increased a bear-call bet on the S&P 500 in a huge way. The fund lifted a put position -- a bet the market will go lower -- on the S&P 500 ETF to its biggest size yet, in terms of value and portfolio percentage, making a 605% leap over the previous quarter.
Bullion Baron, who has long kept a beady eye on Soros's SPY moves, has summed up the latest dealings. He speculated that this could be a hedge -- or Soros is really worried about something. One possible something is China, which the hedge-fund titan referred to as a global uncertainty earlier in the year, notes the Baron.
Sentiment: Strong Sell